Diagnos Laboratorium Utama PT Tbk (DGNS) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.008x

Based on the latest financial reports, Diagnos Laboratorium Utama PT Tbk (DGNS) has a cash flow conversion efficiency ratio of 0.008x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp1.52 Billion ≈ $88.96K USD) by net assets (Rp194.00 Billion ≈ $11.37 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Diagnos Laboratorium Utama PT Tbk market capitalisation for the company's overall valuation and market capitalisation.

Diagnos Laboratorium Utama PT Tbk - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how Diagnos Laboratorium Utama PT Tbk's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Diagnos Laboratorium Utama PT Tbk Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Diagnos Laboratorium Utama PT Tbk ranked by their cash flow conversion efficiency. Explore DGNS cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Central Motek Co Ltd KO:308170	-0.028x
Bio-View Ltd TA:BIOV	0.069x
Agricore CS Holdings Berhad KLSE:0309	0.138x
Tscan Therapeutics Inc NASDAQ:TCRX	-0.399x
North Eastern Carrying Corporation Limited NSE:NECCLTD	-0.030x
Mirasol Resources Ltd V:MRZ	0.915x
TMD Energy Limited NYSE MKT:TMDE	N/A
Promimic AB ST:PRO	-0.024x

Annual Cash Flow Conversion Efficiency for Diagnos Laboratorium Utama PT Tbk (2017–2024)

The table below shows the annual cash flow conversion efficiency of Diagnos Laboratorium Utama PT Tbk from 2017 to 2024. View current stock price of Diagnos Laboratorium Utama PT Tbk for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Rp196.13 Billion ≈ $11.49 Million	Rp27.30 Billion ≈ $1.60 Million	0.139x	+106.49%
2023-12-31	Rp195.59 Billion ≈ $11.46 Million	Rp13.18 Billion ≈ $772.50K	0.067x	+335.77%
2022-12-31	Rp210.43 Billion ≈ $12.33 Million	Rp-6.02 Billion ≈ $-352.51K	-0.029x	-109.80%
2021-12-31	Rp201.80 Billion ≈ $11.82 Million	Rp58.87 Billion ≈ $3.45 Million	0.292x	+10.19%
2020-12-31	Rp99.07 Billion ≈ $5.80 Million	Rp26.23 Billion ≈ $1.54 Million	0.265x	+9.86%
2019-12-31	Rp46.46 Billion ≈ $2.72 Million	Rp11.20 Billion ≈ $656.06K	0.241x	-62.25%
2018-12-31	Rp13.27 Billion ≈ $777.31K	Rp8.47 Billion ≈ $496.20K	0.638x	+388.54%
2017-12-31	Rp3.22 Billion ≈ $188.58K	Rp-712.00 Million ≈ $-41.72K	-0.221x	--

About Diagnos Laboratorium Utama PT Tbk

JK:DGNS Indonesia Diagnostics & Research

Market Cap

$20.36 Million

Rp347.50 Billion IDR

Market Cap Rank

#25143 Global

#547 in Indonesia

Share Price

Rp278.00

Change (1 day)

+3.73%

52-Week Range

Rp140.00 - Rp328.00

All Time High

Rp1408.74